- Filed
- Nov 12, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 10, 2021 | 251.59M sh |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $9.91M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $12.63M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $11.05M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $13.55M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $848.23K |
| Current Assets | Q3 2021 · Dec 31, 2020 | $863.1K |
| Total Assets | Q3 2021 · Sep 30, 2021 | $2.9M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $3.05M |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 150.79M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 136.13M sh |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | −$326.2K |
| Cash And Equivalents | Q3 2021 · Sep 30, 2020 | $390.2K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2019 | $317.45K |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | −$8.64M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | −$8.25M |
| Stockholders Equity | Q3 2021 · Mar 31, 2020 | −$8.69M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | −$8.36M |
| Eps Diluted restated | Q3 2021 · Sep 30, 2020 | −$0.01 |
| Eps Diluted restated | Q3 2021 · Sep 30, 2020 | −$0.01 |
| Eps Basic restated | Q3 2021 · Sep 30, 2020 | −$0.01 |
| Eps Basic restated | Q3 2021 · Sep 30, 2020 | −$0.01 |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $356.31K |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $885.96K |
| Net Income | Q3 2021 · Sep 30, 2020 | −$834.11K |
| Net Income restated | Q3 2021 · Sep 30, 2020 | −$982.46K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$298.27K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$687.71K |
| Gross Profit | Q3 2021 · Sep 30, 2020 | $67.59K |
| Gross Profit | Q3 2021 · Sep 30, 2020 | $222.85K |